The IPKat

AUGUST 13, 2024

Upcoming events Assimilate IP Autumn Courses and Webinars : Protecting Confidential Information, Trade Secrets and Know How : 11 September 2024 Freedom to Operate for Life Sciences and Pharma : 25 & 26 September 2024 Patent and Know How Licensing : 9 & 10 October 2024 IP Essentials – Patent or Trade Secret? Details here.

Intellectual Property 64

Intellectual Property IP Journalism Confidentiality 64

SpicyIP

DECEMBER 2, 2024

The plaintiff through its market survey allegedly found that the defendant was engaged in the business of storing/selling/marketing/distributing products under the falsified trademarks NIKE and Swoosh logo.

Invention 52

Invention Trademark Reporting Editing 52

The IPKat

NOVEMBER 14, 2022

The latter, contrary to what it might appear from its date of adoption (2014), is a regulation that is certainly topical, having started to take effect as of 31 July 2022, with a transitional period that will last until 31 January 2025, but which will see a first and fundamental provision entering into force on 31 January 2023.

IP 78

IP Marketing Marketing Confidentiality 78

LexBlog IP

AUGUST 30, 2023

market on March 7, 2025, if approved by FDA. J&J also recently filed a confidential settlement and license agreement to terminate a Samsung Bioepis challenge to all claims of U.S.

Settlement 40

Settlement Confidentiality Marketing Marketing 40

LexBlog IP

JANUARY 16, 2023

The European Commission expressed its hope that the provisions of the regulation will enter into force across all EU member states in 2025. These include, among others, the use to take decisions that may be detrimental to a natural person or the use for advertising or marketing.

Intellectual Property 52

Intellectual Property Business Confidentiality Advertising 52

LexBlog IP

FEBRUARY 1, 2024

In October 2023, Accord settled with Janssen Biotech under confidential terms that would allow Accord to launch its proposed ustekinumab biosimilar no later than May 15, 2025, pending FDA approval. Accord, a global subsidiary of Intas Pharmaceuticals, will be responsible for U.S. commercialization.

Confidentiality 40

Confidentiality Reporting Licensing Marketing 40

Trading Secrets

NOVEMBER 12, 2024

Part of the reason for changing the pre-merger requirements is the FTCs acknowledgment of market changes, noting the changing nature of competition since the inception of the HSR and the need to respond to such changes.

Reporting 40

Reporting Business Confidentiality Contracts 40

Fish & Richardson Trademark & Copyright Thoughts

FEBRUARY 4, 2021

At the same time, market uptake of biosimilars in the United States continued to increase, suggesting that there is room for expansion of biosimilars in the U.S. In addition, fewer new biosimilars entered the market this past year, with five biosimilar launches in 2020 as compared to seven in 2019. Yet biosimilars of anti-TNF?

Settlement 52

Settlement Litigation Marketing Marketing 52

43(B)log

MARCH 28, 2025

2025 WL 918411, 24cv1646(DLC) (S.D.N.Y. 26, 2025) Previously , the court partially granted Skillzs motion to dismiss Papayas amended counterclaims; Papaya sought leave to file further amended counterclaims, which the court denied. Skillz Platform Inc. Papaya Gaming, Ltd.,

False Advertising 52

False Advertising Advertising Advertising Editing 52

SpicyIP

DECEMBER 31, 2024

Wishing everyone a prosperous and a healthy new year ahead and hoping that 2025 brings in spicier IP developments to the Indian IP regime, making it a more fair, balanced and effective one! Happy 2025! A) Top 10 IP Judgements/Orders (Topicality/Impact) 1. Novex Communications Pvt Ltd v. And with that we end our round-up for this year!

IP 105

IP Invention Patent Copyright 105